Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Tóm tắt
The benefit of whole brain radiotherapy (WBRT) for late stage breast cancer patients with brain metastases has been questioned. In this study we evaluated survival and level of care (hospital or home) following WBRT in a population-based cohort by personal and tumor characteristics. We identified 241 consecutive patients with breast cancer and brain metastases receiving WBRT in Stockholm, Sweden, 1999–2012. Through review of medical records, we collected data on prognostic determinants including level of care before and after WBRT. Survival was estimated using Cox regression, and odds ratios (OR) of not coming home using logistic regression. Median age at WBRT was 58 years (range 30--–88 years). Most patients (n = 212, 88%) were treated with 4 Gray × 5. Median survival following WBRT was 2.9 months (interquartile range 1.1–6.6 months), and 57 patients (24%) were never discharged from hospital. Poor performance status and triple-negative tumors were associated with short survival (WHO 3–4 median survival 0.9 months, HR = 5.96 (3.88–9.17) versus WHO 0–1; triple-negative tumors median survival 2.0 months, HR = 1.87 (1.23–2.84) versus Luminal A). Poor performance status and being hospitalized before WBRT were associated with increased ORs of not coming home whereas cohabitation with children at home was protective. Survival was short following WBRT, and one in four breast cancer patients with brain metastases could never be discharged from hospital. When deciding about WBRT, WHO score, level of care before WBRT, and the patient’s choice of level of care in the end-of-life period should be considered.
Tài liệu tham khảo
Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22:3608–3617
Barnholtz-Sloan JS, Sloan AE, Davis FG et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872
Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13:1648–1655
Frisk G, Svensson T, Backlund LM et al (2012) Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden. Br J Cancer 106:1850–1853
Lin NU, Amiri-Kordestani L, Palmieri D et al (2013) CNS metastases in breast cancer: old challenge, new frontiers. Clin Cancer Res 19:6404–6418
Sperduto PW, Kased N, Roberge D et al (2013) The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer. J Neurooncol 112:467–472
Liu Y, Alexander BM, Chen YH et al (2015) Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases. J Neurooncol 124:429–437
Bergh (2014) Nationellt vårdprogram för bröstcancer. Nationellt vårdprogram för bröstcancer
Fontanella C, De Carlo E, Cinausero M et al (2016) Central nervous system involvement in breast cancer patients: is the therapeutic landscape changing too slowly? Cancer Treat Rev 46:80–88
Nieder C, Norum J, Dalhaug A et al (2013) Radiotherapy versus best supportive care in patients with brain metastases and adverse prognostic factors. Clin Exp Metastasis 30:723–729
Feyer P, Sautter-Bihl ML, Budach W et al (2010) DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis. Strahlenther Onkol 186:63–69
Beccaro M, Costantini M, Giorgi Rossi P et al (2006) Actual and preferred place of death of cancer patients. Results from the Italian survey of the dying of cancer (ISDOC). J Epidemiol Community Health 60:412–416
Nilsson J, Blomberg C, Holgersson G et al (2017) End-of-life care: where do cancer patients want to die? A systematic review. Asia Pac J Clin Oncol. doi:10.1111/ajco.12678
Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500
Noordijk EM, Vecht CJ, Haaxma-Reiche H et al (1994) The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29:711–717
Mintz AH, Kestle J, Rathbone MP et al (1996) A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78:1470–1476
Fokstuen T, Wilking N, Rutqvist LE et al (2000) Radiation therapy in the management of brain metastases from breast cancer. Breast Cancer Res Treat 62:211–216
Broadbent AM, Hruby G, Tin MM et al (2004) Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 71:259–265
Borgelt B, Gelber R, Kramer S et al (1980) The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:1–9
Tsao MN, Lloyd N, Wong RK et al (2012) Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 18(4):CD003869
Edwards A, Gerard G (1998) The management of cerebral metastases. Eur J Pall Care 5:7–11
Ogawa K, Yoshii Y, Nishimaki T et al (2008) Treatment and prognosis of brain metastases from breast cancer. J Neurooncol 86:231–238
Hall WA, Djalilian HR, Nussbaum ES et al (2000) Long-term survival with metastatic cancer to the brain. Med Oncol 17:279–286
Nussbaum ES, Djalilian HR, Cho KH et al (1996) Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 78:1781–1788
Chong JU, Ahn SG, Lee HM et al (2015) Local control of brain metastasis: treatment outcome of focal brain treatments in relation to subtypes. J Breast Cancer 18:29–35
Subbiah IM, Lei X, Weinberg JS et al (2015) Validation and development of a modified breast graded prognostic assessment as a tool for survival in patients with breast cancer and brain metastases. J Clin Oncol 33:2239–2245
Bröstcancerregistret SFN (2014) Årsrapport RAPPORT FRÅN NATIONELLA BRÖSTCANCERREGISTRET 2014
Gu X, Cheng W, Cheng M et al (2015) The preference of place of death and its predictors among terminally ill patients with cancer and their caregivers in China. Am J Hosp Palliat Care 32:835–840